SPEVIGO
NDC 50222-361, spesolimab, injection, from LEO Pharma Inc..
- Product NDC
- 50222-361
- Status
- Listed
- Labeler
- LEO Pharma Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761244
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50222-361 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SPESOLIMAB150 mg/mL
Pharmacologic classes
Interleukin-36 Receptor Antagonist [EPC]; Interleukin-36 Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50222-361-02 | 50222036102 | 2 SYRINGE, GLASS in 1 CARTON (50222-361-02) / 1 mL in 1 SYRINGE, GLASS (50222-361-11) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/78a4f7eb-8d34-4467-8d40-74ed24323806
Use it
Look up 50222-361 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50222-361 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50222-361. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.